GD

Gayatri Devi

Active Director Director DIN 11082303
DIN 11082303 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Gayatri Devi

Data last updated:

Gayatri Devi is a Director at Kovial Biotech Private Limited (since 2025). The company operates in Pharma. Kovial Biotech Private Limited reported revenue of ₹3.43 Cr (FY 2025).

DIN 11082303
Primary Designation Director
Industry Pharma
First Appointment 29 Apr 2025
Oldest Company Age 5 yrs
Largest company Kovial Biotech Private Limited · ₹3.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kovial Biotech Private Limited U24100HP2021PTC008643
Director29 Apr 20252021₹3.43 Cr (FY 2025)Active

Board colleagues of Gayatri Devi

NameDINCompanyDesignation
Pushpendra Singh07454065Kovial Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kovial Biotech Private Limited
Premium access

Shareholding and investment profile for Gayatri Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gayatri Devi

Gayatri Devi currently holds 1 directorship: Kovial Biotech Private Limited (Director, since 29 Apr 2025, revenue ₹3.43 Cr (FY 2025)).

Gayatri Devi was first appointed on 29 Apr 2025 as Director at Kovial Biotech Private Limited.

The current boards of Gayatri Devi's companies include Pushpendra Singh (Kovial Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available